Showing results (321-330 of 391) with videos related to

Sort By:
Pageof 40
Oncology and Therapy|July 1, 2025
Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal TumoursJoris M van Sabben, Maud B A van der Kleij, Evelyne Roets, et al.
Oncology and Therapy|April 12, 2025
Clinical and Dosimetric Predictors of Early Onset Postradiation Hypothyroidism in Patients with Head and Neck Malignancies: A Logistic Regression AnalysisAhmad Ameri, Zohreh Azma, Khashayar Fattah, et al.
Oncology and Therapy|May 17, 2025
A Cost-Effectiveness Analysis for Avelumab as a First-Line Maintenance Treatment of Advanced Urothelial Carcinoma in the NetherlandsDavid Smalbrugge, Tim Walsteijn, Jeantine de Feijter, et al.
Oncology and Therapy|May 8, 2025
Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World OutcomesHiroya Taniguchi, Kiyohiro Nishikawa, Tatsuo Haneji, et al.
Oncology and Therapy|May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment PathwayStefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Oncology and Therapy|November 8, 2025
Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative ReviewMarina E Cazzaniga, Luis Costa, Gilles Freyer, et al.
Oncology and Therapy|September 13, 2025
Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaTalha Munir, Nicolás Martinez-Calle, Sheng Xu, et al.
Oncology and Therapy|September 14, 2025
Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST StudyBenoît Godbert, Elisa Gobbini, Chantal Decroisette, et al.
Oncology and Therapy|January 3, 2023
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder CancerSaachi Chhaya, Isabella Watts, Kenrick Ng, et al.
Oncology and Therapy|June 25, 2022
Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA MutationYonaton Zarbiv, Yael Berner Wygoda, Albert Grinshpun, et al.
Pageof 40